ZA963590B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA963590B
ZA963590B ZA963590A ZA963590A ZA963590B ZA 963590 B ZA963590 B ZA 963590B ZA 963590 A ZA963590 A ZA 963590A ZA 963590 A ZA963590 A ZA 963590A ZA 963590 B ZA963590 B ZA 963590B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA963590A
Inventor
Peter David Holtshousen
Original Assignee
Adcock Ingram Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adcock Ingram Ltd filed Critical Adcock Ingram Ltd
Publication of ZA963590B publication Critical patent/ZA963590B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
ZA963590A 1995-05-10 1996-05-07 Pharmaceutical composition ZA963590B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA953778 1995-05-10

Publications (1)

Publication Number Publication Date
ZA963590B true ZA963590B (en) 1996-11-19

Family

ID=25585074

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA963590A ZA963590B (en) 1995-05-10 1996-05-07 Pharmaceutical composition

Country Status (3)

Country Link
AU (1) AU5655696A (en)
WO (1) WO1996035452A1 (en)
ZA (1) ZA963590B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1311907B1 (en) * 1999-04-06 2002-03-20 Zambon Spa DEGLUTABLE TABLETS WITH HIGH CONTENT OF N-ACETYLCISTEIN.
AU2003205974A1 (en) * 2002-02-13 2003-09-04 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising terbutaline or salbutamol in combination with guaiphenesine
ES2471139T3 (en) 2003-08-06 2014-06-25 Galephar M/F Advantageous combinations for the inhalation of nacysteline and bronchodilators
CN1303065C (en) * 2004-05-20 2007-03-07 江苏豪森药业股份有限公司 Ambroxol cysteine analogs and their preparation process and use thereof
CN101291660A (en) * 2005-09-20 2008-10-22 加林制药公司 Combination s-nitrosothiol-based pharmaceutical products for restoring normal breathing rhythm
EP1857106A1 (en) * 2006-05-16 2007-11-21 Edmond Pharma S.R.L. Combinations of erdosteine and beta-2 agonists for treating COPD
BRPI0718199A2 (en) * 2006-10-03 2013-11-12 Galleon Pharmaceuticals Inc COMPOSITION AND METHODS FOR STABILIZING A MAMMAL'S BREATHING RATIO, AND INCREASING MINUTE VENTILATION AT AN INDIVIDUAL'S NUCLEUS TRACTUS SOLITARIUS RESPIRATORY CONTROL CENTERS.
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US20120252824A1 (en) * 2009-06-16 2012-10-04 John Brew Drug Combinations and Uses in Treating a Coughing Condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
CN102596189A (en) * 2009-09-12 2012-07-18 雷克特本克斯尔有限责任公司 Use of guaifenesin for inhibiting mucin secretion
WO2011142677A1 (en) * 2010-05-11 2011-11-17 Breathe Easy Ltd Methods and compositions for the treatment of lung disorders
TR201723198A2 (en) * 2017-12-30 2019-07-22 Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi Compositions containing Erdosteine and ascorbic acid.
CN113018444A (en) * 2020-01-09 2021-06-25 海南斯达制药有限公司 Pharmaceutical composition for treating respiratory system diseases and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7992091A (en) * 1990-05-21 1991-12-10 Norwich Eaton Pharmaceuticals, Inc. The use of phenylpropanolamine as a mucus secretogogue in the upper airways
ZA921848B (en) * 1991-05-10 1992-11-25 South African Druggists Ltd Pharmaceutical composition
ES2074769T3 (en) * 1991-07-01 1995-09-16 Gergely Gerhard PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH AT LEAST TWO DIFFERENT ACTIVE PRINCIPLES AND USE OF A PREPARATION OF THIS TYPE.
ZA935931B (en) * 1992-08-18 1994-03-07 South African Druggists Ltd Pharmaceutical composition
ZA94155B (en) * 1992-11-06 1995-07-11 Adcock Ingram Pharma Pharmaceutical composition
BE1007926A3 (en) * 1994-01-31 1995-11-21 Zambon Int Pharma Pharmaceutical composition containing n-acetyl-cysteine.

Also Published As

Publication number Publication date
AU5655696A (en) 1996-11-29
WO1996035452A1 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
HU9601698D0 (en) Pharmaceutical composition
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
ZA967827B (en) Pharmaceutical compositions
GB9519667D0 (en) Pharmaceutical composition
ZA962214B (en) Pharmaceutical composition
ZA963590B (en) Pharmaceutical composition
EG24294A (en) Pharmaceutical compositions
GB9506382D0 (en) Pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
ZA9610426B (en) Pharmaceutical composition
ZA961051B (en) Pharmaceutical composition
ZA964193B (en) Pharmaceutical composition
ZA963591B (en) Pharmaceutical composition
HU9602822D0 (en) Pharmaceutical composition
ZA95736B (en) Pharmaceutical composition
HUP9602732A3 (en) Pharmaceutical composition comprising lanperisone
GB9515207D0 (en) Pharmaceutical composition
GB9515723D0 (en) Pharmaceutical composition
GB9505369D0 (en) Pharmaceutical composition
ZA9510132B (en) Pharmaceutical composition
HU9903430D0 (en) Pharmaceutical composition
GB9519748D0 (en) Pharmaceutical composition
ZA961735B (en) Pharmaceutical composition
GB9505368D0 (en) Pharmaceutical composition